Latest China News

Osteopore Limited posted a 10% quarter-on-quarter revenue increase to AUD 754K in Q1 CY26, driven by new distribution deals across China, Latin America, and Hong Kong, alongside launching 3D printing services and securing innovative bone graft technologies in Asia Pacific.

AdAlta has launched its East-to-West cellular immunotherapy strategy through a co-development deal for CAR-T therapy BZDS1901, showing promising complete tumour clearance in mesothelioma patients and transferring manufacturing to Australia to boost scalability.

Appen Limited’s Q1 FY26 revenue rose 9% year-on-year to $54.8 million, driven by an 88% surge in its China business. Despite a 37% drop in the Global segment due to seasonality, the company reaffirmed full-year guidance and highlighted expanding AI operational efficiencies.

Estrella Resources has initiated Timor-Leste’s inaugural hard rock mineral extraction at its Ira Miri manganese project, advancing towards full-scale mining and simultaneously progressing a major limestone resource at Werumata.

Australian Strategic Materials reports a 70% surge in NdFeB alloy production, installs pilot heavy rare earth furnace, and progresses its acquisition by Energy Fuels with regulatory approvals underway.

Energy Metals Limited (ASX: EME) reported a 12% increase in uranium resources at its Bigrlyi Project to 10,900 tonnes U3O8, driven by successful drilling and modelling. The company plans to advance technical studies and further exploration in 2026, supported by a solid cash position and strategic backing from China General Nuclear Power Group.

CurveBeam AI reported stable device orders but faces regulatory delays for FDA and China clearances, while securing a A$4 million investment from WEGO Orthopaedics and advancing clinical collaborations with robotic surgery systems.

Talga Group reported record anode production at its EVA plant and significant progress on its 5,000tpa Vittangi anode plant FEED study, alongside strategic partnerships and exploration breakthroughs.

PhosCo Ltd has reported rock chip assays up to 21.3% copper and 100 g/t silver from the King’s Eye prospect within its Simitu Project in northern Tunisia, alongside geophysical evidence of sulphide mineralisation at depth warranting immediate follow-up.

Mayne Pharma’s third quarter results show modest revenue growth but a sharp improvement in cash flow and earnings, powered by the strong launch of DistributeRx and robust Women’s Health sales.

Victory Metals has reported record rare earth oxide grades and exceptional metallurgical results at its North Stanmore project, alongside strategic partnerships and heritage clearances that unlock exploration potential.

Volt Resources has secured a major extension and volume increase to its Bunyu graphite offtake agreement while progressing high purity graphite production and downstream refinery development in the US.